Realbotix (XBOT.F) Q1 2026 earnings summary

Executive summary

• Addressed prior weaknesses in financial controls and reporting, now resolved with a new CFO and improved systems.

• Revenue for Q1 2026 was $353,037, a significant decrease from $815,655 in Q1 2025 due to discontinued crypto staking, increased competition, and a strategic shift to AI and robotics markets.

• Net loss from continuing operations improved to $1.3 million from $1.7 million year-over-year, aided by lower operating expenses and a one-time gain from debt repayment.

• Revenue growth is a key focus, with increased marketing and sales efforts following the exit from crypto staking.

• The Onconetix Nasdaq reverse takeover deal is expected to unlock significant value, though market reaction has been muted.

Financial highlights

• Sold Tokens.com domain for nearly $2.5 million, boosting cash reserves.

• Exited crypto at favorable prices, stabilizing treasury in cash.

• Gross margin declined to 32.2% in Q1 2026 from 43.6% in Q1 2025.

• Operating expenses reduced to $1.7 million from $1.9 million year-over-year.

• Currently debt-free with a strong balance sheet and sufficient cash runway.

Outlook and guidance

• Revenue expected to increase in the coming year, with no specific targets provided.

• Launching AI-only products to generate recurring monthly revenue.

• Anticipates improved margins and manufacturing efficiency as new facility comes online.

• Ongoing discussions with major clients, including a trial with a leading North American retailer.

• Management indicates over 12 months of capital runway at the current monthly cash burn rate of $425,000, excluding unforeseen expenses.